Myriad Genetics reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Accelerate Diagnostics AXDX:US 115.92M 7.94M
Agilent A:US $ 2730M 0M
Becton, Dickinson and BDX:US $ 17584M 1224M
Bio Rad Laboratories BIO:US $ 1196.74M 1186.22M
Biocept BIOC:US $ 1.22M 0.21M
Bruker BRKR:US $ 1205.4M 16.4M
Danaher DHR:US $ 21768M 400M
Exact Sciences EXAS:US $ 2193.28M 0.55M
Fluidigm FLDM:US $ 100.03M 35.82M
Hologic HOLX:US $ 2833.4M 7.5M
Illumina ILMN:US $ 1241M 454M
Johnson & Johnson JNJ:US $ 28851M 1134M
Mettler Toledo International MTD:US 1.77B 186.02M
Myriad Genetics MYGN:US $ 0M 0M
Nanostring Technologies NSTG:US $ 225.51M 0.37M
Orasure Technologies OSUR:US $ 1.21M 0.74M
Pacific Biosciences Of California PACB:US $ 896.22M 0.15M
Perkinelmer PKI:US $ 4863.98M 115.76M
Quest Diagnostics DGX:US $ 3985M 25M
Quidel QDEL:US $ 0M 0M
Repligen RGEN:US $ 0M 0M
Thermo Fisher Scientific TMO:US $ 31389M 944M
Veracyte VCYT:US $ 0.6M 0M
Waters WAT:US $ 1444.12M 69.75M